LQDA FY 2025 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$158M+1031.2% YoY

Gross Profit

$154M97.2% margin

Operating Income

-$51M-32.5% margin

Net Income

-$69M-43.5% margin

EPS (Diluted)

$-0.80

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$40M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$328M

Total Liabilities

$283M

Stockholders' Equity

$45M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$158M	$14M	+1031.2%
Gross Profit	$154M	$8M	+1796.0%
Operating Income	-$51M	-$121M	+57.6%
Net Income	-$69M	-$130M	+47.1%